Skip to main content
Premium Trial:

Request an Annual Quote

ProGenTech Inks Deal with Aussie Firm for HAI Tests

NEW YORK (GenomeWeb News) – ProGenTech has inked an alliance with Sydney, Australia-based Human Genetic Signatures to develop a line of molecular diagnostic assays for hospital-acquired infections.
Under the agreement, HGS will develop assays for methicillin-resistant Staphylococcus aureus, methicillin-sensitive Staphylococcus aureus, vancomycin-resistant Enterococcus, and Clostridium difficile. The assays will be integrated into ProGenTech’s Entura platform, which the company said reduces sample preparation time by preloading all reagents for RNA, DNA, and protein applications in a cassette.
ProGenTech said that it anticipates manual assays for the HAIs will be taken to the US Food and Drug Administration next year followed by fully integrated and automated tests in 2010. If the tests are cleared for marketing they will represent ProGenTech’s initial foray into the molecular diagnostics field.
The underpenetrated HAI market is being pursued by a variety of molecular diagnostics firms, who will compete with Cepheid and Becton Dickinson, the two firms that have already received US and European marketing clearance for a variety of HAI tests and plan to expand their test menus in this market.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.